Literature DB >> 23832742

Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells.

Suman Sengupta1, Samir Jana, Subir Biswas, Palash Kumar Mandal, Arindam Bhattacharyya.   

Abstract

Epithelial to mesenchymal transition (EMT) is a secondary phenomenon concomitantly associated with the tumor progression. The regulatory signals and mechanistic details of EMT are not fully elucidated. Here, we shared a TGF-β mediated mechanism of EMT in breast cancer (MDA-MB 231) cells. Initial exposure of TGF-β for 48 h, enhanced the rate of cell proliferation and associated with EMT of MDA-MB 231 cells. The EMT was characterized by observing the increased N-cadherin, fibronectin, Snail expression and associated with the morphological change with a reduced E-cadherin expression. NFAT, a transcription factor, alters tumor suppressive function of TGF-β towards tumor progression. Up regulation of NFAT, coupled with a foremost translocation of one oncogenic protein SnoN from cytoplasm to nucleus was noticed during this TGF-β mediated EMT. Silencing of NFAT also showed the inhibition of TGF-β mediated EMT characterized by down regulation of N-cadherin and associated with reduced expression of SnoN. In addition, it was also observed that NFAT sequestering the Smad3 prevents the proteasome mediated degradation of SnoN and this SnoN has a role on the regulation of MMP-2, MMP-9 activity. Increased Smad3-SnoN interaction and proteasome mediated degradation of SnoN were detected after silencing of NFAT with a reduced MMP-2, MMP-9 activity. All of these observations provide a fresh mechanism in which by a twofold involvement of NFAT and SnoN plays a crucial role in TGF-β mediated EMT by recruiting the effector molecules N-cadherin and MMP-2, MMP-9.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23832742     DOI: 10.1007/s10585-013-9600-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  51 in total

Review 1.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

2.  Proto-oncogene Sno expression, alternative isoforms and immediate early serum response.

Authors:  S Pearson-White; R Crittenden
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

Review 3.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

4.  Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells.

Authors:  W C Duivenvoorden; H W Hirte; G Singh
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

Review 5.  Ski/Sno and TGF-beta signaling.

Authors:  X Liu; Y Sun; R A Weinberg; H F Lodish
Journal:  Cytokine Growth Factor Rev       Date:  2001-03       Impact factor: 7.638

6.  Role of transforming growth factor-beta signaling in cancer.

Authors:  M P de Caestecker; E Piek; A B Roberts
Journal:  J Natl Cancer Inst       Date:  2000-09-06       Impact factor: 13.506

7.  TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation.

Authors:  S Bonni; H R Wang; C G Causing; P Kavsak; S L Stroschein; K Luo; J L Wrana
Journal:  Nat Cell Biol       Date:  2001-06       Impact factor: 28.824

8.  Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.

Authors:  Sung Woon Pyo; Mitsuyoshi Hashimoto; Young Sill Kim; Chang Hyen Kim; Sang Hwa Lee; Keith R Johnson; Margaret J Wheelock; Je Uk Park
Journal:  J Craniomaxillofac Surg       Date:  2007-02-12       Impact factor: 2.078

9.  Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation.

Authors:  Garima Singh; Shiv K Singh; Alexander König; Kristina Reutlinger; Monica D Nye; Tillman Adhikary; Martin Eilers; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

Review 10.  Roles of TGFbeta in metastasis.

Authors:  David Padua; Joan Massagué
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

View more
  13 in total

Review 1.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

Review 2.  Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer.

Authors:  Ayesha Khalid; Joy Wolfram; Ilaria Ferrari; Chaofeng Mu; Junhua Mai; Zhizhou Yang; Yuliang Zhao; Mauro Ferrari; Xiaojing Ma; Haifa Shen
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

3.  Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.

Authors:  Lingmei Li; Lisha Qi; Zhijie Liang; Wangzhao Song; Yanxue Liu; Yalei Wang; Baocun Sun; Bin Zhang; Wenfeng Cao
Journal:  Int J Mol Med       Date:  2015-05-25       Impact factor: 4.101

4.  Arf6 regulates EGF-induced internalization of E-cadherin in breast cancer cells.

Authors:  Rui Xu; Yujie Zhang; Luo Gu; Jianchao Zheng; Jie Cui; Jing Dong; Jun Du
Journal:  Cancer Cell Int       Date:  2015-02-04       Impact factor: 5.722

5.  Tamoxifen Action in ER-Negative Breast Cancer.

Authors:  Subrata Manna; Marina K Holz
Journal:  Sign Transduct Insights       Date:  2016-02-10

6.  The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells.

Authors:  C Tran Quang; S Leboucher; D Passaro; L Fuhrmann; M Nourieh; A Vincent-Salomon; J Ghysdael
Journal:  Cell Death Dis       Date:  2015-02-26       Impact factor: 8.469

7.  Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.

Authors:  Johanna Eriksson; Vadim Le Joncour; Pirjo Nummela; Tiina Jahkola; Susanna Virolainen; Pirjo Laakkonen; Olli Saksela; Erkki Hölttä
Journal:  Oncotarget       Date:  2016-03-22

8.  Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease.

Authors:  Angeles C Tecalco-Cruz; Diana G Ríos-López; Genaro Vázquez-Victorio; Reyna E Rosales-Alvarez; Marina Macías-Silva
Journal:  Signal Transduct Target Ther       Date:  2018-06-08

9.  NFATC3-PLA2G15 Fusion Transcript Identified by RNA Sequencing Promotes Tumor Invasion and Proliferation in Colorectal Cancer Cell Lines.

Authors:  Jee-Eun Jang; Hwang-Phill Kim; Sae-Won Han; Hoon Jang; Si-Hyun Lee; Sang-Hyun Song; Duhee Bang; Tae-You Kim
Journal:  Cancer Res Treat       Date:  2018-06-14       Impact factor: 4.679

Review 10.  Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy.

Authors:  Wei Wang; Atif Zafar; Mehrdad Rajaei; Ruiwen Zhang
Journal:  Cells       Date:  2020-05-09       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.